Search
Mizuho Senior Biotech Analyst Salim Syed shares his take on 2025 and key catalysts from companies he covers
He discusses BridgeBio, Cytokinetics, Wave, Vaxcyte, Iovance, Unity, and Enliven
Feb 11
Mizuho senior analyst Salim Syed joins BiotechTV for Analyst Thursdays from the New York Stock Exchange
Salim Syed gives his take on Cytokinetics, BridgeBio, Enliven, Vaxcyte, and Wave Life Sciences.
Jun 6, 2024
Mizuho analyst Salim Syed joins Analyst Thursdays to talk about this week’s news from Cytokinetics, Gilead, and more
Salim Syed discusses this morning’s FOREST-HCM update, Gilead’s Trodelvy news, CRISPR’s allo CAR-T pivot, and more.
Jan 25, 2024
Mizuho’s Salim Syed returns to BiotechTV for Analyst Thursdays
Salim Syed talks about his recent initiation on CRISPR Therapeutics, and comments on Wave Life Sciences, BridgeBio, Atara, and Cytokinetics.
Oct 5, 2023
Mizuho's Salim Syed joins BiotechTV for Analyst Thursdays
Salim Syed gives his take on biotech and discusses BridgeBio, Cytokinetics, Wave Life Sciences, and Atara Biotherapeutics.
Jul 20, 2023
.png){kind=logo}
